Brian Pinker, 6, received the Oxford University / AstraZeneca Covid-19 vaccine on January 4, 2021 from nurse Sam Foster at Churchill Hospital in Oxford, south-west England.
Person Steve | AFP | Getty Images
LONDON – The UK has begun rolling out a coronavirus vaccine developed by AstraZeneca and Oxford University, another step in its fight against the coronavirus epidemic.
The country’s National Health Service (NHS) is the first in the world to deploy Jab after the Medicines and Healthcare Products Regulatory Agency (MHRA) approved it for use in the UK last week. The NHSA said Brian Pinker, 6, was the first person in the world to receive a job on Monday morning.
The approval and deployment of the Ox Xford-AstraZeneca vaccine is seen as a boon in the race against the Covid-19, as it is cheaper than the alternatives created by Pfizer and Bioentech and Modern.
Additionally, and unlike the rival vaccine, it can be stored, transported, and handled in normal refrigerated conditions (2 to 8 સે C or 36 to 46 ફેર F) for at least six months.
When the vaccine was approved last week, AstraZeneca said it was “supplying millions of doses in the first quarter” as part of a deal with the UK government to bring the total to 100 million doses.
As a two-dose vaccine, the agreement could mean the inoculation of around 50 million people in the UK, with a population of around 66 million.
In a statement on Monday, the UK government said that now that the quality of batches has been verified by the MHRA, more than કરોડ 1 million will be delivered in the coming weeks and months.
The Oxford-AstraZeneca vaccine adds to the Covid-19 vaccination program already launched by Britain in December, when it began rolling out the two-dose Pfizer-Bioentech vaccine. More than a million people in the UK have already received the Pfizer shot vaccine, according to the government. It said on Monday that more than 730 vaccination sites had been set up across the UK and hundreds more were opening this week.
Like the Pfizer vaccine, the Ox Xford-AstraZeneca shot will be sent first to priority groups, including care home residents and staff, people over the age of 80 and health and care workers, then to the rest of the population in age and risk order, including those who are clinically extremely vulnerable. .
‘Main moment’
“This is an important moment in our fight against this dreaded virus and I hope it gives everyone new hope that this epidemic is coming to an end,” said UK Health Secretary Matt Hancock.
A second vaccine rollout for the UK could not come soon, which is struggling with an increase in infections, mainly due to mutations in the virus that spread it more easily. According to Johns Hopkins University, there are now more than 2.6 million cases of the virus in the UK and more than 75,000,000 people have died to date.
UK Prime Minister Boris Johnson said on Sunday that there were likely to be more restrictions on public life as the Covid-19 case escalated.
On Monday, Hancock told Sky News that the UK would not bring vaccines faster than supply approvals but experts agreed that the UK needed to move its vaccination program forward as soon as possible. Last week, a study by the London School of Hygiene and Tropical Medicine concluded that Britain must vaccinate two million people a week to avoid a third wave of coronavirus outbreaks.
On Saturday, the Times unofficially quoted the “key member of the Oxford-AstraZeneca team” as saying that the drugmaker would accelerate production to create two million pockets per week in mid-January.
Cardiff University School of Medicine Reader of Infectious Diseases. He told CNBC on Monday that the pace of the rollout “depends on the availability of the vaccine, also on the production of the vaccine, its distribution and the establishment of new vaccination centers and the recruitment of new vaccinators.”
“It’s a goal, but it’s real and I think it can be achieved by the end of the month,” he told CNBC’s “Squawk Europe X Europe.” “
Hundreds of doctors a week before surgeries and care are mostly supplied to homes, individuals at high risk will first be vaccinated by shots given early in hospitals.
Somewhat controversially, the MHRA, the Joint Vaccination and Immunization Joint Committee (JCVI) and four UK chief medical officials have now agreed to delay the gap between the first and second doses of the coronavirus vaccine, which is now given to the public. He said the change in strategy allowed for the protection of the largest number of people in the short term.
The British Medical Association said the decision to delay follow-up doses of the Pfizer vaccine and to cancel appointments for patients already scheduled for a second dose was “absolutely unfair” to thousands of at-risk patients. However, experts such as Friedman said that for a vaccine like the Ox Xford-AstraZeneca candidate, long intervals between doses could increase the effectiveness of JAB.
The government insisted last week that “many people in priority risk groups should be given their first dose instead of the required two doses as soon as possible.”
“Everyone will still receive their second dose and this will be within 12 weeks of their first week. The second dose completes the course and is important for long-term protection,” he added.
.
